What is Puralab?
Puralab operates as a specialized research and development entity, providing critical analytical services across the medical device, cosmetic, and nutraceutical sectors. With a core focus on ISO 13485 compliance, the company bridges the gap between conceptual design and market-ready product manufacturing. Their expertise spans skin health research, microbiology testing, and infection control technologies, making them a vital partner for emerging enterprises that require sophisticated design control practices to ensure product safety and efficacy. By offering pilot-scale manufacturing, Puralab effectively lowers the barrier to entry for innovators looking to bring high-quality supplements and medical solutions to the global market.
How much funding has Puralab raised?
Puralab has raised a total of $19K across 1 funding round:
Debt
$19K
Debt (2021): $19K with participation from PPP
Key Investors in Puralab
PPP
Public-Private Partnership
What's next for Puralab?
With the recent injection of capital, Puralab is expected to scale its R&D infrastructure and enhance its pilot manufacturing capacity. The strategic focus will likely remain on deepening its technical expertise in infection control and expanding its footprint in the nutraceutical and vitamin sectors. As the company matures through its current growth stage, the emphasis will shift toward optimizing supply chain efficiencies and securing further regulatory milestones, ensuring that their clients maintain a competitive edge through affordable, compliant, and scientifically validated product development cycles.
See full Puralab company page
